Provided by Tiger Trade Technology Pte. Ltd.

Annovis Bio, Inc.

1.75
-0.0700-3.85%
Pre-market: 1.73-0.0200-1.14%08:53 EDT
Volume:670.72K
Turnover:1.18M
Market Cap:74.45M
PE:-0.98
High:1.83
Open:1.83
Low:1.74
Close:1.82
52wk High:5.50
52wk Low:1.54
Shares:42.54M
Float Shares:35.32M
Volume Ratio:1.11
T/O Rate:1.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7895
EPS(LYR):-1.4040
ROE:-703.68%
ROA:-142.36%
PB:-17.50
PE(LYR):-1.25

Loading ...

Annovis Bio to Host Corporate Update Webinar with Live Q&A Session

Reuters
·
1 hour ago

Annovis Bio - Phase 3 Alzheimer's Disease Trial Fully Enrolled; Top-Line Data and Submissions Expected in 2027

THOMSON REUTERS
·
1 hour ago

Annovis Bio - Open-Label Alzheimer's Study for Buntanetap to Begin October 2026

THOMSON REUTERS
·
1 hour ago

Annovis to Host Corporate Update Webinar on September 2, 2026

GlobeNewswire
·
1 hour ago

Annovis Bio Announces Special Shareholder Meeting

Reuters
·
3 hours ago

Analysts Offer Insights on Healthcare Companies: Annovis Bio (ANVS) and Acurx Pharmaceuticals (ACXP)

TIPRANKS
·
Aug 20

Annovis Bio’s New Long-Term Safety Study Puts Buntanetap Back in the Alzheimer’s Spotlight

TIPRANKS
·
Aug 20

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 17

Annovis Bio Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Annovis Bio Q2 Loss Widens as R&D Costs Rise

Reuters
·
Aug 14

Annovis Bio Q2 EPS $(0.40) Beats $(0.45) Estimate

Benzinga Earnings
·
Aug 14

Annovis Bio Q2 EPS USD -0.4

THOMSON REUTERS
·
Aug 14

Press Release: Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results

Dow Jones
·
Aug 14

Annovis Bio Inc Expected to Post a Loss of 45 Cents a Share - Earnings Preview

Reuters
·
Aug 07

Annovis Bio Completes Enrollment in Pivotal Alzheimer’s Trial

TIPRANKS
·
Jul 10

Annovis Bio Completes Enrollment in Phase 3 Early Alzheimer’s Trial of Buntanetap

Reuters
·
Jul 10

Analysts’ Top Healthcare Picks: Evolus (EOLS), Annovis Bio (ANVS)

TIPRANKS
·
Jul 09

Annovis Bio Initiated at Buy by Roth Capital

Dow Jones
·
Jul 08

Annovis Bio initiated with a Buy at Roth Capital

TIPRANKS
·
Jul 08

Annovis Bio announces full enrollment for buntanetap trial

TIPRANKS
·
Jul 07